STOCK TITAN

Owlet, Inc. - $OWLT STOCK NEWS

Welcome to our dedicated page for Owlet news (Ticker: $OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Owlet's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Owlet's position in the market.

Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) to participate in BTIG Digital Health Forum on November 20, 2023. Kurt Workman and Kate Scolnick to engage in fireside chat at 11 a.m. Eastern Time. 1x1 meetings with management available upon request through BTIG.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.61%
Tags
conferences
-
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) Reports Q3 2023 Financial Results and FDA Authorization for Dream Sock®. Achieved revenues of $9.2 million, de novo FDA-authorization for Dream Sock, and a shift in Amazon revenue arrangement. Operating expenses reduced to $11.2 million compared to $26.4 million in 2022. Gross margin increased to 36.3% from 26.6% in the same period in 2022. Financial outlook to be discussed in the conference call on November 13, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.61%
Tags
-
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) announces FDA De Novo clearance for Dream Sock, the first over-the-counter medical pulse oximetry solution for infants. The cleared features include monitoring and displaying Baby’s Live Health Readings, pulse rate, and oxygen saturation level, and providing Health Notifications. This sets new standards in at-home infant care, providing enhanced peace of mind for parents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
none
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) will release its Q3 2023 results on November 13, 2023. The earnings release will be available on Business Wire and Owlet's Investor Relations website. A conference call will be hosted by CEO Kurt Workman and CFO Kate Scolnick at 4:30 p.m. ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences earnings
-
Rhea-AI Summary
Owlet partners with Dr. Harrington and Knox Blocks Foundation to raise funds for SIDS research, aiming to identify biomarkers and develop preventative screenings. SIDS claims over 3,000 babies' lives annually in the US. Owlet donates 5% of global sales in October to the project. Owlet also supports parents through various initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
-
Rhea-AI Summary
Owlet, Inc. announces the appointment of Marc Stoll to its Board of Directors. Stoll brings over 25 years of experience in finance and technology industries and will help bolster Owlet's future ventures and growth potential. He has expertise in corporate strategy and operational excellence. Stoll's appointment will accelerate the company's global growth strategies in consumer and medical product distribution channels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.48%
Tags
management
Rhea-AI Summary
Owlet reports Q2 2023 financial results, with revenues of $13.1 million, a 22% increase from Q1 2023. Operating expenses declined 21% to $11.9 million. Gross margin improved to 40% from 36.1% in Q2 2022. The company received FDA clearance for BabySat™, its pulse-oximetry device, and remains on track with the de novo submission for Health Notifications software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.42%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
conferences earnings
-
Rhea-AI Summary
Owlet, Inc. announces the appointment of Jonathan Harris as its new President and Chief Revenue Officer. Harris has over 30 years of experience and a proven track record in leading go-to-market strategies for top brands. He joins Owlet after the FDA clearance of BabySat™, the first medical pulse-oximetry device with Owlet's wire-free sock design. Harris will work with the executive team to accelerate go-to-market strategies and expand both consumer and medical product lines.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.21%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
management
Owlet, Inc.

NYSE:OWLT

OWLT Rankings

OWLT Stock Data

38.10M
5.70M
11.27%
44.52%
3.34%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LEHI